Oct 05, 2021
The family of Henrietta Lacks--a Black woman whose "immortal" cells were taken without her consent or knowledge 70 years ago--on Monday sued a pharmaceutical company over its "unjust enrichment" as a result of profits based on the stolen tissue that transformed modern medicine.
"This isn't just about social justice. This is about genetic justice," Ben Crump, a lawyer for the Lacks family, said at a press conference.
The filing in the U.S. district court in Baltimore accuses Thermo Fisher Scientific of "making a conscious choice to sell and mass produce the living tissue of Henrietta Lacks, a Black woman, grandmother, and community leader, despite the corporation's knowledge that Ms. Lacks' tissue was taken from her without her consent by doctors at Johns Hopkins Hospital and a racially unjust medical system."
"A human being--Henrietta Lacks--is behind every cell, every sample sold by Thermo Fisher Scientific," the filing states.
\u201cToday marks 70 YEARS since Henrietta Lacks' death. We have filed a lawsuit against the US biotech giant Thermo Fisher Scientific for unjustly enriching their company by using her cells w/o consent! We are seeking #geneticjustice for Lacks' family! https://t.co/wBwNhhsO71\u201d— Ben Crump (@Ben Crump) 1633386972
The cells were taken from a biopsy when Lacks went to Johns Hopkins Hospital in 1951 for treatment for cervical cancer. Because of the cells' unique ability to live on and even reproduce in laboratory settings after 24 hours, hers "were the first known immortalized human cell line," which then became known as the HeLa cell line, as the lawsuit explains.
Nine months after that tissue was taken, Lacks died of cervical cancer at the age of 31. It wasn't until decades later that her family learned of the sample taken.
"The HeLa cell line is one of the most important and widely used cell lines in human history," the filing states, pointing to the cell line's role in innovations including the polio vaccine and in vitro fertilization.
The family estate's lawyers also said "Thermo Fisher Scientific has made staggering profits by using the HeLa cell line--all while Ms. Lacks Estate and family haven't seen a dime," pointing to 2020 alone when the company "recorded $32.22 billion in revenue."
While Henrietta Lacks' role in the cell line was obfuscated for years, thanks in part to a best-selling book and film based on it, "there is a widespread consensus today that the theft of Ms. Lacks' cells was profoundly unethical and wrong," according to the lawsuit.
Join Us: News for people demanding a better world
Common Dreams is powered by optimists who believe in the power of informed and engaged citizens to ignite and enact change to make the world a better place. We're hundreds of thousands strong, but every single supporter makes the difference. Your contribution supports this bold media model—free, independent, and dedicated to reporting the facts every day. Stand with us in the fight for economic equality, social justice, human rights, and a more sustainable future. As a people-powered nonprofit news outlet, we cover the issues the corporate media never will. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
The family of Henrietta Lacks--a Black woman whose "immortal" cells were taken without her consent or knowledge 70 years ago--on Monday sued a pharmaceutical company over its "unjust enrichment" as a result of profits based on the stolen tissue that transformed modern medicine.
"This isn't just about social justice. This is about genetic justice," Ben Crump, a lawyer for the Lacks family, said at a press conference.
The filing in the U.S. district court in Baltimore accuses Thermo Fisher Scientific of "making a conscious choice to sell and mass produce the living tissue of Henrietta Lacks, a Black woman, grandmother, and community leader, despite the corporation's knowledge that Ms. Lacks' tissue was taken from her without her consent by doctors at Johns Hopkins Hospital and a racially unjust medical system."
"A human being--Henrietta Lacks--is behind every cell, every sample sold by Thermo Fisher Scientific," the filing states.
\u201cToday marks 70 YEARS since Henrietta Lacks' death. We have filed a lawsuit against the US biotech giant Thermo Fisher Scientific for unjustly enriching their company by using her cells w/o consent! We are seeking #geneticjustice for Lacks' family! https://t.co/wBwNhhsO71\u201d— Ben Crump (@Ben Crump) 1633386972
The cells were taken from a biopsy when Lacks went to Johns Hopkins Hospital in 1951 for treatment for cervical cancer. Because of the cells' unique ability to live on and even reproduce in laboratory settings after 24 hours, hers "were the first known immortalized human cell line," which then became known as the HeLa cell line, as the lawsuit explains.
Nine months after that tissue was taken, Lacks died of cervical cancer at the age of 31. It wasn't until decades later that her family learned of the sample taken.
"The HeLa cell line is one of the most important and widely used cell lines in human history," the filing states, pointing to the cell line's role in innovations including the polio vaccine and in vitro fertilization.
The family estate's lawyers also said "Thermo Fisher Scientific has made staggering profits by using the HeLa cell line--all while Ms. Lacks Estate and family haven't seen a dime," pointing to 2020 alone when the company "recorded $32.22 billion in revenue."
While Henrietta Lacks' role in the cell line was obfuscated for years, thanks in part to a best-selling book and film based on it, "there is a widespread consensus today that the theft of Ms. Lacks' cells was profoundly unethical and wrong," according to the lawsuit.
The family of Henrietta Lacks--a Black woman whose "immortal" cells were taken without her consent or knowledge 70 years ago--on Monday sued a pharmaceutical company over its "unjust enrichment" as a result of profits based on the stolen tissue that transformed modern medicine.
"This isn't just about social justice. This is about genetic justice," Ben Crump, a lawyer for the Lacks family, said at a press conference.
The filing in the U.S. district court in Baltimore accuses Thermo Fisher Scientific of "making a conscious choice to sell and mass produce the living tissue of Henrietta Lacks, a Black woman, grandmother, and community leader, despite the corporation's knowledge that Ms. Lacks' tissue was taken from her without her consent by doctors at Johns Hopkins Hospital and a racially unjust medical system."
"A human being--Henrietta Lacks--is behind every cell, every sample sold by Thermo Fisher Scientific," the filing states.
\u201cToday marks 70 YEARS since Henrietta Lacks' death. We have filed a lawsuit against the US biotech giant Thermo Fisher Scientific for unjustly enriching their company by using her cells w/o consent! We are seeking #geneticjustice for Lacks' family! https://t.co/wBwNhhsO71\u201d— Ben Crump (@Ben Crump) 1633386972
The cells were taken from a biopsy when Lacks went to Johns Hopkins Hospital in 1951 for treatment for cervical cancer. Because of the cells' unique ability to live on and even reproduce in laboratory settings after 24 hours, hers "were the first known immortalized human cell line," which then became known as the HeLa cell line, as the lawsuit explains.
Nine months after that tissue was taken, Lacks died of cervical cancer at the age of 31. It wasn't until decades later that her family learned of the sample taken.
"The HeLa cell line is one of the most important and widely used cell lines in human history," the filing states, pointing to the cell line's role in innovations including the polio vaccine and in vitro fertilization.
The family estate's lawyers also said "Thermo Fisher Scientific has made staggering profits by using the HeLa cell line--all while Ms. Lacks Estate and family haven't seen a dime," pointing to 2020 alone when the company "recorded $32.22 billion in revenue."
While Henrietta Lacks' role in the cell line was obfuscated for years, thanks in part to a best-selling book and film based on it, "there is a widespread consensus today that the theft of Ms. Lacks' cells was profoundly unethical and wrong," according to the lawsuit.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.